These cells accumulate within the breast tumor microenvironment, where they inhibit T cell activation primarily through the secretion of enzymes and molecules such as arginase-1, inducible nitric oxide synthase (iNOS), and reactive oxygen species [43]. Here, NOS2 is linked to breast neoplasm.